LIDOCAINE HYDROCHLORIDE ANHYDROUS

N/A

Manufactured by Spectra Medical Devices, LLC

13,967 FDA adverse event reports analyzed

Last updated: 2026-04-15

About LIDOCAINE HYDROCHLORIDE ANHYDROUS

LIDOCAINE HYDROCHLORIDE ANHYDROUS is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Spectra Medical Devices, LLC. The most commonly reported adverse reactions for LIDOCAINE HYDROCHLORIDE ANHYDROUS include INFUSION SITE PAIN, NAUSEA, DRUG INEFFECTIVE, OFF LABEL USE, INFUSION SITE ERYTHEMA. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for LIDOCAINE HYDROCHLORIDE ANHYDROUS.

Top Adverse Reactions

INFUSION SITE PAIN638 reports
NAUSEA451 reports
DRUG INEFFECTIVE439 reports
OFF LABEL USE398 reports
INFUSION SITE ERYTHEMA393 reports
DYSPNOEA391 reports
HEADACHE391 reports
DIARRHOEA380 reports
FATIGUE343 reports
PAIN319 reports
DIZZINESS286 reports
INFUSION SITE SWELLING270 reports
VOMITING264 reports
HYPOTENSION220 reports
INFUSION SITE HAEMORRHAGE191 reports
CARDIAC ARREST185 reports
MALAISE165 reports
PNEUMONIA161 reports
PYREXIA159 reports
ARTHRALGIA157 reports
PAIN IN EXTREMITY157 reports
TOXICITY TO VARIOUS AGENTS157 reports
PRODUCT USE IN UNAPPROVED INDICATION142 reports
ANXIETY139 reports
DRUG HYPERSENSITIVITY139 reports
ASTHENIA135 reports
ANAEMIA134 reports
BACK PAIN133 reports
THERAPY NON RESPONDER133 reports
DRUG INTERACTION132 reports
WEIGHT DECREASED130 reports
HYPERTENSION124 reports
INFUSION SITE INFECTION123 reports
COUGH122 reports
DECREASED APPETITE121 reports
LOCAL ANAESTHETIC SYSTEMIC TOXICITY120 reports
RASH120 reports
INFUSION SITE DISCHARGE118 reports
ANAPHYLACTIC SHOCK114 reports
DEATH114 reports
DEVICE DISLOCATION113 reports
INSOMNIA113 reports
CONDITION AGGRAVATED111 reports
ABDOMINAL PAIN110 reports
CONSTIPATION108 reports
DEVICE FAILURE108 reports
FEELING ABNORMAL108 reports
PLATELET COUNT DECREASED108 reports
FEBRILE NEUTROPENIA107 reports
WEIGHT INCREASED106 reports
OVERDOSE103 reports
BRADYCARDIA100 reports
DEVICE ISSUE100 reports
DEVICE INFUSION ISSUE99 reports
PRURITUS99 reports
DERMATITIS CONTACT98 reports
FALL98 reports
CHEST PAIN97 reports
ERYTHEMA97 reports
OXYGEN SATURATION DECREASED95 reports
INFUSION SITE INDURATION94 reports
INFUSION SITE REACTION93 reports
MYALGIA92 reports
PERIPHERAL SWELLING89 reports
SEIZURE88 reports
WHITE BLOOD CELL COUNT DECREASED88 reports
INJECTION SITE PAIN87 reports
PALPITATIONS85 reports
DEVICE LEAKAGE83 reports
ILLNESS83 reports
LOSS OF CONSCIOUSNESS83 reports
MIGRAINE82 reports
PRODUCT USE ISSUE82 reports
ANAPHYLACTIC REACTION81 reports
INFUSION SITE PRURITUS81 reports
CHILLS80 reports
DEVICE MAINTENANCE ISSUE80 reports
DEVICE OCCLUSION80 reports
INFUSION SITE IRRITATION80 reports
ABDOMINAL DISTENSION79 reports
HYPERSENSITIVITY79 reports
PRODUCT DOSE OMISSION ISSUE77 reports
PAIN IN JAW75 reports
TREMOR74 reports
DEVICE USE ERROR72 reports
CONFUSIONAL STATE71 reports
HYPOKALAEMIA71 reports
NASOPHARYNGITIS71 reports
NEUTROPHIL COUNT DECREASED71 reports
DEVICE MALFUNCTION70 reports
HYPOXIA70 reports
INFUSION SITE WARMTH68 reports
TACHYCARDIA68 reports
SOMNOLENCE67 reports
DRUG INTOLERANCE65 reports
HEART RATE INCREASED65 reports
HYPOAESTHESIA65 reports
ABDOMINAL DISCOMFORT64 reports
INFLUENZA64 reports
POOR QUALITY SLEEP64 reports

Report Outcomes

Out of 6,009 classified reports for LIDOCAINE HYDROCHLORIDE ANHYDROUS:

Serious 70.4%Non-Serious 29.6%

The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.

Demographics Breakdown

Reports by Sex

Female3,525 (64.0%)
Male1,929 (35.0%)
Unknown53 (1.0%)

Reports by Age

Age 66115 reports
Age 62102 reports
Age 50100 reports
Age 5395 reports
Age 6893 reports
Age 5286 reports
Age 6382 reports
Age 6782 reports
Age 5481 reports
Age 7081 reports
Age 6979 reports
Age 3678 reports
Age 6578 reports
Age 7476 reports
Age 6474 reports
Age 5673 reports
Age 5772 reports
Age 5972 reports
Age 6071 reports
Age 7169 reports

Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.

Frequently Asked Questions

How many FDA adverse event reports are associated with LIDOCAINE HYDROCHLORIDE ANHYDROUS?

This profile reflects 13,967 FDA FAERS reports that mention LIDOCAINE HYDROCHLORIDE ANHYDROUS. Reporting is voluntary and does not prove that the drug caused any listed event.

Which adverse reactions are most often listed for LIDOCAINE HYDROCHLORIDE ANHYDROUS?

Frequently reported terms in FAERS include INFUSION SITE PAIN, NAUSEA, DRUG INEFFECTIVE, OFF LABEL USE, INFUSION SITE ERYTHEMA, DYSPNOEA. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.

Who manufactures LIDOCAINE HYDROCHLORIDE ANHYDROUS?

Labeling and FAERS entries often list Spectra Medical Devices, LLC in connection with LIDOCAINE HYDROCHLORIDE ANHYDROUS. Always verify the specific product and NDC with your pharmacist.

Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.